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ABSTRACT 
Thermal balloon ablation is a modern non surgical procedure for the treatment of 
menorrhagia. It works on the principle of ablating the endometrial layer beyond a point of 
regeneration thereby reducing blood loss. Mathematical modelling of this procedure helps in 
improving accuracy of the treatment which reduces adverse affects of the procedure thereby 
making the procedure safer. Pennes bio-heat equation is used to calculate transient 
temperature in the uterine cavity. Thermal injury integral is used to calculate the irreversible 
thermal destruction of the uterine tissue. When thermal injury integral equals to or is greater 
than 1, the tissue is destroyed which prevents regeneration of the endometrium. The 
presented mathematical model is verified with the published experimental findings to check 
the validity of the model. The effect of overall convective heat transfer coefficient and 
balloon fluid temperature on tissue damage is studied. For an overall convective heat transfer 
coefficient above 2000Wm-2K-1, maximum depth of ablation at 87°C was 3.77mm. For 
higher fluid temperature, depth of ablation is found to increase. At a fluid temperature of 
93°C, depth of ablation is found to be 4.39mm for an overall convective heat transfer 
coefficient 1000Wm-2K-1. The temperature at the surface of endometrium is found to increase 
with the increase in fluid temperature and also with the increase in overall convective heat 
transfer coefficient. The obtained results are valid in the absence of any pathological 
condition. In case of existing pathological conditions, the effects caused by them are also to 
be included. Thus, mathematical modelling involving convective heat losses is an effective 
tool to make thermal balloon procedure more accurate.  
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1.1 HISTORICAL REVIEW: 
The fact that menstruation is a normal physiological process of female reproductive system is 
obvious, but in the earlier centuries it was considered to be an impure phase of every 
woman’s life. Pliny the elder, back in the first century AD, represented the way menstruation 
was viewed. It was then considered as an unpleasant event of a women’s life. However, this 
thought has changed to a modernised one by nineteenth century AD. H.Beckwith white house 
described menstruation in academic context as- “one of the sacrifices to be offered by woman 
at the altar of evolution and civilization” [1]. 
There were very few medical textbooks that dealt with the disorders of menstruation process. 
It was Hippocrates who described abnormal uterine bleeding for the first time around 460 BC 
[1]. Until 1800’s the description mostly reflected abnormal bleeding symptoms as excessive 
bleeding described as heavy evacuations of the menses, inordinate flowing, immoderate flux, 
an overflowing of courses, menstruation to be too profuse, excessive flooding, and uterine 
haemorrhage [2]. The medical text books of Hippocrates were later translated and quoted by 
Aristotle as- “in quantity, bleeding is excessive saith Hippocrates, when they flow about 
eighteen ounce.” But the fact that eighteen ounce is about 540ml. is quite shocking to know 
since it is about seven times the maximum limit. In the middle part of the seventeenth 
century, William Heberlen, a gynaecologist and successful physician provided earliest and 
best description of abnormal uterine bleeding available till then [1]. 
None of the early writers used terms like ‘menorrhagia’ or ‘metrorrhagia’ until the later parts 
of seventeenth century [2]. The term menorrhagia was used for the first time by William 
Cullen, professor at the university of Edinburg [1, 2]. According to Cullen, menorrhagia was 
a disease involving deviations from normal which are too high in degree and causes a state of 
disability [2]. To be particular, the term “menorrhagia rubra” was used for non puepperal 
women and “menorrhagia abortus” was used for pregnant women [1]. The term 
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“menorrhagia” was first found in treatise by a postgraduate student of Cullen which was 
attributed to him.  Exact spelling used by Cullen was “maetrorrhagia” [2]. Fleetwood 
Churchill, a specialist in gynaecology described the abnormalities associated with uterine 
bleeding as “metrorrhagia” in his medical books which later came to be known as 
“menorrhagia” [1]. However, the roots arise from Greek language which is from the merge of 
words “mene” and “regnumi” as “menorrhaga”.  “mene” is moon and the verb “regnumi” is 
to burst forth [1-3]. Graves used the term “dysfunctional uterine bleeding” for the first time 
which according to him meant “impairment of endocrine factors” which is similar to regular 
or irregular menorrhagia or disturbances that were caused during ovulation state [1, 2]. 
To know the causes that lead to menorrhagia, firstly it is needed to know the menstrual cycle, 
formation and shedding of the endometrium, and the abnormalities associated with it. This 
primarily deals with the structure and biological characteristics of the uterus. Uterus can be 
described as a hollow organ, about the size of a medium pear and is the place where a foetus 
grows and develops when a woman is pregnant [4]. It has two main parts. The upper part is 
called the body of the uterus which is scientifically coined as corpus (meaning body in Latin) 
and the lower part which extends into the vagina called the cervix. The body of the uterus in 
turn comprises of two layers- the inner layer and the outer layer. The inner layer is termed as 
the endometrium and the outer layer of muscle is called the myometrium that pushes the baby 
out during birth. The tissue that coats the outer side of the uterus is known as the serosa. 
Hormonal changes during the menstrual cycle of a woman result in the change of the 
endometrium [4]. 
In the early part of the menstrual cycle, that is before the ovaries release an egg (ovulation), 
they produce estrogens and this thickens the endometrium so that it could nourish the embryo 
if pregnancy occurs during that cycle. In the absence of pregnancy, estrogen is produced in 
lesser amounts and another hormone called the progesterone is produced in higher amounts 
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after ovulation which causes the innermost layer of the lining to get prepared for shedding 
[4]. In general, normal shedding of the endometrial (menstruation) occurs as a result of 
stimulation of the endometrial lining by the physiologic levels of estrogen and progesterone 
which are maintained in a balanced state during the normal ovulatory cycle, followed by the 
rapid withdrawal of these two hormones [5]. The stimulation of these hormones causes the 
shedding of endometrium and by the end of the menstrual cycle, the endometrial lining is 
shed from the uterus which becomes the menstrual flow (period). This cycle repeats 
throughout a woman's life until menopause [4]. 
In the modern scientific approach, menorrhagia is defined as prolonged menstrual bleeding. 
During a normal period, the bleeding lasts for about 7 days to a maximum in a 21-35 day 
cycle with a volume flow measuring about 25-80 ml. So, menorrhagia can be described as 
loss of blood more than 80ml per cycle lasting more than 7 days [1, 6-12]. 
Until the eighteenth century reason for menorrhagia was guessed by Aristotle. It was thought 
that excessive uterine bleeding was due to heating of blood, trauma, or due to breaking of 
veins. Later, by the middle of eighteenth century several interesting hypothesis came into 
existence. Dewees, from his observations described the cause for heavy menstrual bleeding in 
women with some imbalance in daily activities like little or no exercise, intemperate nature, 
irregular dancing, having several child bearings, who were affected by some infections in the 
past, who were at their advancement of non menstrual period, who yielded to passions or 
emotions easily. In the book The Married Woman’s Private Medical Companion, written by 
Mauriceau some other causes as per his observations were stated [1]. Women who had 
miscarriages in the past, weak women, women who underwent heavy exercise, highly obese 
women are prone to have fair chances of suffering from menorrhagia. 
In nineteenth century, introduction of anaesthesia was a great boon to humanity. It paved a 
way to perform complicated surgeries effectively. Apart from that, the sample specimens 
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could also be studied with greater efficiency. Advancement in science and technology helped 
in revealing the facts of physiological problems [1]. This lead to careful and close 
examination of uterus cavity and the thought of some surgical operation to be performed as a 
cure to menorrhagia paved its way. 
By the earlier part of twentieth century, the causes for uterine fibroids were found which was 
a reason for heavy menstrual bleeding; but endometrium associated problems were not 
discovered until the later parts of the century. It was Samson, whose studies paved a major 
contribution in learning the causes of menorrhagia [1]. 
1.2. LITERATURE REVIEW: 
The terms “abnormal uterine bleeding”, “dysfunctional uterine bleeding”, “menorrhagia” 
though have similar meanings; there is a slight difference when keenly learnt. Dysfunctional 
uterine bleeding is a part of abnormal uterine bleeding and menorrhagia is the term used 
when the earlier stated definition holds true, i.e., loss of more than 80ml. of blood per 
menstrual cycle for more than 7 days [1, 6-12]. 
In general, causes of abnormal uterine bleeding can be classified into four categories. The 
first one being the organic causes- caused due to infection, endometrial polyps, pregnancy 
and malignancy; the second type being the systemic causes- as a result of imbalances of 
system such as thyroid, liver or renal diseases; the third kind called iatrogenic- holds the 
effects caused by glucocortico steroids, steroid hormones, intra uterine devices containing 
copper; the fourth category referred to as idiopathic- holds good for the cases where no 
definite cause could be identified and such an abnormal uterine bleeding can be termed as 
‘dysfunctional uterine bleeding’ (DUB)[7]. 
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DUB is generally caused as a result of continuous stimulation of the endometrial layer with 
unopposed estrogen that occurs due to a dysfunction of the hypothalamic-pituitary-ovarian 
axis [5]. DUB can also be caused by uterine fibroids, inflammatory diseases of the pelvis, 
imbalances of hormones such as estrogen and progesterone, high levels of prostaglandins and 
endothelins which may lead to menorrhagia [8]. Sometimes, DUB may also be caused due to 
improper functioning of the endometrium causing erratic responses, insufficient progesterone 
and anvoulary cycles [7]. Disorders of thyroid, liver, and kidney might also turn up to be a 
cause of extensive uterine bleeding [8]. Menorrhagia causes are generally associated with 
pathologies like polypi of the endometrium and adenomyosis [6]. 
 It is found that about 30% of pre menopausal women are suffering from menorrhagia during 
their child bearing years [8, 9]. Most of the people view menorrhagia as a common problem 
associated with women in recent years. As inferred from the records, 25% of the women 
undergo hysterectomy below the age of 60 [6]. Women suffering from menorrhagia have fair 
chances of experiencing pain in the lower part of the abdomen [3]. 
There are other problems caused by menorrhagia, as the personal life of an individual is 
observed. Anaemia is the mostly observed disorder caused due to menorrhagia [9]. Loss of 
blood beyond a presumable limit may cause a deficiency in the amount of blood and thereby 
related iron deficiency disorders. Moreover, it is related to social, economical and 
physiological well being of a woman [9]. A great deal of physical as well as mental stress, 
discomfort, embarrassment might also be caused [9]. Frequent mood swings, irritation, often 
frustration, which change the way of life, have a profound impact in the lives of women who 
suffer from menorrhagia disorder.  
Before confirming menorrhagia, certain tests are to be done. Physiologically, though it is 
defined as loss of more than 80ml of blood, it is confirmed only after certain investigations 
are done, so as to rule out uterine pathology [13]. Endometrial biopsy eliminates the chances 
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of endometrial cancer thereby providing scope for confirming menorrhagia [13]. Various 
tests that are carried out include blood tests, ultrasound testing, endometrial biopsy, and 
hysteroscopy (a visual examination of the uterus) [8]. 
The first line of approach for treatment of menorrhagia is drug based; which includes various 
drugs like oral contraceptives, inhibitors of prostaglandin synthesis, progestagens, anti 
fibrinolytics and hormone releasing intra uterine systems [10]. Apart from drugs, a traditional 
drug therapy might also be employed which involves medical therapy with hormones, non 
steroidal anti inflammatory drugs, anti prostaglandins. But their side effects in the long run 
might be unacceptable [11]. Sometimes, medical treatments for menorrhagia might be quite 
ineffective and there is a fair chance of side effects [14]. Hence, when a non surgical 
treatment is provided, future implications need to be kept under consideration. 
After the drug or hormonal based treatment, the most preferred procedures are the surgical 
procedures termed as second line of approach for the treatment of menorrhagia [10]. 
Menorrhagia was treated in the past by hysterectomy, myomectomy, and dilation and 
cutterage [10, 15]. In United States, hysterectomy is one of the most common surgical 
procedures [6].  The widely available effective treatment procedure until recent past was 
hysterectomy in which a surgical operation is carried out to remove the uterus [8]. According 
to National centre for health statistics, hysterectomy is the second most performed surgical 
procedure after caesarean delivery [15]. Hysterectomy has been 100% successful proving out 
its effectiveness [8]. 
 But the main drawbacks for hysterectomy are its high costs, morbidity, and complex surgical 
procedure [8, 14, 16]. Moreover, surgical treatment of hysterectomy requires a great deal of 
skill and experience of gynaecologist who performs it [19]. Removing the entire uterus was 
inevitable for some disorders while in others all that was needed was a reduction in blood 
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outflow. In dysfunctional uterine bleeding the only problem was heavy bleeding and 
removing the entire uterus was not a choice to be preferred. This led to other procedures 
which are precise only to the problem of heavy bleeding. Thus, non-surgical procedures were 
developed. These non-surgical methods are improved further by employing mathematical 
models which are solved by Pennes bio heat equation to describe transient temperature in 
tissues. Parameters like temperature of ablation, depth of ablation, treatment time are studied 
by formulating mathematical equations. In a study by Baldwin et al., high temperatures for a 
short time period are analysed and cases of vaporisation and no vaporisation are considered 
[27]. In another study, transient temperatures across uterine cavity are determined by 
employing finite element analysis. It is found that temperature across uterus depends strongly 
on the perfusion coefficient and is affected by rate of decay of the fluid temperature [38]. Yet, 
another study is based on enthalpy method that accounts for liquid to vapour change at 
elevated temperatures. Phase change occurrence and complete suppression of perfusion have 
shown to be the factors effecting ablation depth [16].  
 
1.3. METHODS OF ABLATION: 
The concept that ablating the endometrial layer causes reduction in menstrual flow led to the 
development of new technologies [3]. Hence, the first generation techniques were designed. 
These included three suitable techniques to ablate the endometrium namely: 
· Roller ball technique,  
· Nd–YAG laser ablation, and  
· Transcervical resection of endometrium (TCRE) [7,20].  
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All the three procedures had almost similar outcomes when post operative readings were 
taken [12]. But these first generation techniques were of less efficiency, longer duration, 
required skill and had life threatening complications which led to the further development of 
new techniques [14, 16]. 
These new methods were termed as the second generation ablation methods which were easy 
to perform, less time consuming and of good efficiency [16, 17]. These procedures were 
developed on the concept of ablating the endometrial layer beyond a point of regeneration 
selectively, which inhibits the endometrium formation and therefore causes a reduction in 
menstrual flow [8]. A less invasive treatment is thermal endometrial ablation, in which 
endometrium regeneration is inhibited by forming scar tissue on the wall of uterus [14, 22, 
23]. Endometrial ablation has advantages as compared to the surgical procedures in the past 
that it can be an office-based procedure which does not require general anaesthesia or total 
removal of the uterus [14]. These technologies ablate the entire surface of endometrium 
hence are also called as global ablation techniques instead of ablating the selective regions as 
in rollerball elecctrosurgery or laser surgery [15]. 
However, thermal endometrial ablation has its own risks and complications which include 
thermal damage to the bowel, urinary bladder, cervix, uterus, and pelvic blood vessels [14]. 
There are quite a good number of second generation procedures and they are preferred for 
their simplicity in performance. They are easily performed in a clinical setting rather than in 
an operative surgical setting [20]. These include: 
1. Balloon systems 
2. Intrauterine laser devices 
3. Multi-electrode radio-frequency ablation 
4. Bipolar impedance controlled ablation 
5. Hot saline instillation systems 
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6. Microwave energy 
7. Cryo-ablation therapy 
8. Chemical cautery of the endometrium 
9. Photodynamic therapy 
Food and Drug Administration (FDA) has approved use of five global endometrial methods 
namely thermal balloon ablation, circulating hot fluid, ablation using microwave energy, 
cryotherapy, and radio frequency ablation. All these five methods have recorded high 
satisfaction rates with lesser complications [15, 24]. The devices termed for each of the 
procedures, production details can be obtained from below. 
FDA-Approved Endometrial Ablation Devices [7]: 
1. ThermaChoice, Uterine Balloon Therapy System, GyneCare, Ethicon, A Johnson & 
Johnson Company, Menlo Park, California. 
2. Hydro ThermAblator Endometrial Ablation System, BEI Medical Systems, Boston 
Scientific, Teterboro, New Jersy. 
3. Her Option Uterine Cryoblation Therapy System, CryoGen, American Medical 
Systems, San Diego, California. 
4. NovaSure Impedance Controlled Endometrial Ablation System, Novacept, Palo Alto, 
California. 
5. Microwave endometrial ablation (MEA, Microsulis Medical, Hampshire, UK) [16] 
The first four endometrial devices are available in the United States [7]. In the above devices 
microwave endometrial ablation is not included initially. Microwave ablating device has been 
introduced by the clinicians of National Institute of Clinical Excellence (NICE), United 
Kingdom [16].  
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However, there are certain contradictions when endometrial ablation is not preferred. In such 
cases ablating the endometrium should never be a choice to be opted. Some of such cases are 
[15]: 
· Pregnancy or desire to be pregnant in the future 
· Premalignant change in the endometrium 
· Active pelvic inflammatory disease  
· Carcinoma of the endometrium 
· Classic caesarean delivery or transmural myomectomy in the past 
· Uterine abnormalities such as separate uterus, bicornuate uterus, or unicornuate uterus 
· Active urinary tract infection  
· Refusal or intolerance to medical treatment. 
· Endometrial hyperplasia or malignancy. 
 
In exception to the above conditions, ablation of endometrium is a good choice to be 
opted. Discussing various methodologies numbered above in detail gives a good idea 
regarding the ablation of endometrium. 
1. Circulating hot fluid: 
This is approved by the FDA in 2001 [15]. When fluid is infused through the cervix at 
pressures below 70 mm Hg, it will not spill into the peritoneal cavity and this principle is 
used in hydrothermal ablation devices [20]. It is a software-controlled thermal ablation 
system designed in the form of a closed loop system that circulates hot saline at 90°C in the 
endometrial cavity [4, 9]. An external canister is the heating source for this saline [5]. A 
polycarbonate sheath having an outer diameter of 7.8 mm is fitted over a standard 3mm 
hysteroscope for fluid circulation [15, 20]. Saline with a concentration of 0.9% is infused 
through the inflow channel [16, 25].  
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Before circulating the heated fluid, a priming phase is carried out for inspecting the 
endometrial cavity during which room temperature saline is circulated within the endometrial 
cavity at a flow rate of about 300 ml/min, for 2 min [15]. The next phase called the active 
treatment phase causes the heating element to gradually heat the fluid under low pressure of 
about 55mm Hg, which is a pressure below the fallopian tube opening pressures [15]. 
 
2. Cryo ablation therapy: 
Her Option is approved by the FDA in 2001. This device uses cryotherapy in the form of a 
cryoprobe which is cooled by pressurized gas to create temperatures of -100°C to -120°C at 
the tip of the probe [15]. The device consists of a cryoprobe which is about 5-5.5 mm in 
diameter and is disposable [7, 20]. When the cryoprobe is placed within the endometrial 
cavity, an ice ball is produced as a result of such low temperatures [15]. Transabdominal 
ultrasonography is used in monitoring the placing of cryoprobe and formation of ice ball. It is 
inserted into the uterus for two freeze–thaw cycles to complete total treatment [20]. In the 
FDA trial, two freeze cycles of 4 and 6 min were used [15]. The probe is placed into each 
cornu which develops a cytotoxic freeze zone that resurrects the endometrial layer [7]. The 
duration of treatment is about 10-15min [7]. 
 
3. Radiofrequency Thermal Ablation: 
The NovaSure endometrial ablation system gained FDA approval in the year 2001 and is 
based upon the principle of using energy from bipolar radiofrequency to vaporise the 
endometrial lining [15].  A cavity perforation test is performed prior to the initiation of 
ablation where carbon dioxide is diffused into the uterine cavity. It ensures that pressure is 
maintained and vacuum is produced which keeps the array intact with the endometrium [15, 
20]. Once the device is set into function and tissue destruction is initiated, the electrical 
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impedance of the tissue increases with the depth of ablation [15]. When the impedance 
between the tissue and electrode reaches about 50 ohms or when the total treatment time is 
1.5-2 min, the procedure is stopped [7, 15]. 
 
4. Microwave Thermal Ablation: 
In 2003, FDA approved microwave endometrial ablation device, which uses microwave 
energy to destroy the endometrium [15]. It is based on the principle of using electromagnetic 
energy to ablate the endometrium [20]. It consists of a hand-held applicator which applies 
microwaves at a frequency of 9.2GHz through the cervix to the endometrial lining, and a 
temperature level between 75°C and 85°C [15, 20]. A maximum depth of 6mm can be 
ablated [15, 20]. The treatment time varies between 3-5min for a normal sized uterus [15, 
20]. There is a control unit that records treatment profiles when each probe is used, thereby 
facilitating the collection of data [20].  
 
 
5. Uterine Balloon Therapy: 
It is the first approved treatment by FDA [15]. It consists of a balloon that is disposable 
(made of silicone or latex) which is placed into the uterine cavity and is filled with fluid made 
of 5% dextrose and water that maintains its temperature from a central heating element [7, 
15, 17, 18, 20]. Initially the balloon is inserted into the endometrial cavity and is inflated by 
introducing the fluid [15]. The inflation of the balloon causes a pressure in the uterine cavity 
which ensures a good contact of balloon with the uterine cavity [20]. Usually the pressure is 
between 160-180 mm Hg [7, 15]. Treatment time is about 8 min, and the usual fluid 
temperature maintained in the balloon is 87°C [7, 15].  
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The system used for uterine balloon ablation is called Thermachoice system. There are three 
kinds of Thermachoice systems available. Thermachoice I was approved initially which is 
used for patients with greater thickness of the endometrium. It is featured with a dip-moulded 
latex device filled with non-circulating saline solution [26]. It ablates to a depth of 6.3mm 
and ablating to such greater depths could cause perforation of the organs nearer to the uterus 
[24]. Then a modified form of uterine balloon ablation was introduced known as 
Thermachoice II which is used for patients with lower thickness of endometrium as it ablates 
to a depth of 4.77mm [24]. It has a silicone balloon which is introduced in the uterine cavity 
along with a circulation mechanism, thus providing more even ablation of the endometrium 
[26]. Further improvement in Thermachoice systems lead to the development of 
Thermachoice III which ablated endometrium to a thickness of 3.52mm [24]. This model had 
a stronger and more flexible silastic balloon and it confirms better to the contours of the uterine cavity 
and thus increases coverage of cornua and lower uterine segment causing effective ablation [26]. 
 Mostly 5% dextrose and water is used as the circulating fluid [15]. But there are certain other 
fluids that are used by heating separately and then are induced in the balloon. This ablation 
device is termed as Cavaterm [20, 22]. The most recent balloon ablation system is 
Thermablate, which has a biocompatible liquid within a disposable catheter-balloon and the 
unit is heated to an initial temperature of 173 °C. It is forced into an intra-uterine balloon 
through a series of cycles of pressurisation and depressurisation for a treatment period of 2 
min thus causing ablation in a very short period of time [20]. 
Thermachoice gained FDA approval in 2001 and since then it has been widely used in 
comparison to other procedures [15]. The average list prices for different disposable units of 
thermal ablation procedures are $650.00 for the ThermaChoice and Hydro ThermAblator; 
$850.00 for the NovaSure; and $1,200.00 for the Her Option treatment [7]. From the prices it 
could clearly be differentiated why Thermachoice is the most widely used practice for 
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thermal ablation. Its affordable cost and being the first procedure to be approved by the FDA, 
most of the patients prefer Thermachoice. Although HydroThermAblator has the same price, 
the procedural risks involved might be high in comparison to Thermachoice. Hence, we have 
chosen uterine balloon therapy.  
.   
1.4 FACTORS UNDER CONSIDERATION: 
There are certain conditions under which uterine balloon therapy is not preferred [13, 28]: 
· A patient who is already pregnant or who wishes to become pregnant in the future. 
· History of urinary allergy. 
·  A patient suffering with uterine cancer or is suspected to have endometrial cancer. 
· A patient with a condition in which the myometrium could be weak like those who 
might have undergone previous caesarean section or transmural myomectomy. 
·  Active genital tract or urinary infection at the time of procedure. 
 
Precautions in using a Thermachoice system are [13, 28]: 
· To be used in women who have completed childbearing. 
· It is not a sterilised procedure. Therefore, pregnancies after ablation can be dangerous 
for both mother and foetus. 
· Thermal endometrial ablation does not eliminate the risk for endometrial hyperplasia 
or cancer thereby masking a physician’s ability to diagnose such pathology. 
· In a treatment cycle, the patients are to be treated only once. 
· Caution is to be taken so as not to perforate the uterine cavity while performing the 
procedure or ultrasound. If any perforation is present, the procedure needs to be 
abandoned immediately.  
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Before performing uterine balloon ablation therapy, certain investigations are to be made 
such as: 
· Good history and examination of the uterine cavity 
· Sonography so as to rule out any uterine pathology. 
· Tests so as to rule out endometrial cancer such as PAP smear and endometrial biopsy. 
As this procedure involves ablation in the uterine cavity itself, local anaesthesia serves the 
purpose. It helps in reducing pain to the patient, thus making the procedure more 
comfortable. Moreover, there is no dilation performed prior to ablation; hence there is no 
requirement of general anesthesia. Local anaesthetic drugs like 1% Lidocaine or bupivacaine 
with or without rapid acting drugs like fentanyl and a benzodiazepine such as midazolam 
gives sufficient pain relief [13]. 
The thermal balloon endometrial ablation process is safer and does not require much 
expertise [22, 23, 29]. The results obtained are comparable to major surgical procedures [22]. 
Outcomes include amenorrhea, hypomenorrhea in most of the cases and bleeding is greatly 
reduced after thermal balloon endometrial ablation [20, 29]. Therefore, using thermal balloon 
procedure for endometrial ablation is preferred in recent days.  
Endometrial ablation by thermal balloon procedure involves heat transfer through uterine 
cavity which can be presented as a mathematical model. This model involves various 
parameters such as overall heat transfer coefficient, temperature, and thermal injury integral 
that contribute to the depth of ablation. Varying these parameters and studying their effect on 
uterine cavity helps in the betterment of the procedure. 
While performing thermal balloon ablation, as the heat diffuses across the uterine cavity, a 
convective heat loss is associated with it. Calculating the reduction in temperature due to the 
convective heat loss helps in optimizing the process and gives more exact result regarding the 
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fluid temperature that should be used. Studying the effect of fluid temperature and overall 
convective heat transfer coefficient on ablation depth is the objective of this study. 
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CHAPTER-2 
MATHEMATICAL MODELING 
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2.1. MODEL DESCRIPTION: 
Endometrial ablation of uterine cavity as a treatment for menorrhagia can be considered as a 
simple model in which the heat from the silicone balloon traverses in one dimension 
throughout the cavity along the endometrium, myometrium and the serosa. Endometrium 
varies in thickness from 1mm to 4mm in most of the normal women. For a thickness of less 
than 4mm, abnormalities are rarely observed [31, 32]. There are cases where women with 
endometrial thickness greater than 4mm do not suffer from menorrhagia necessarily but 
greater the thickness, greater the liability of the disorder as it is observed in women. In a 
research on post menopausal women, endometrial thickness up to 5mm was considered to be 
normal [33, 34, 40]. In another case study on women suffering from abnormal bleeding, the 
correlation of endometrial thickness and abnormality was found to be up to 4mm for post 
menopausal women and up to 5mm for pre menopausal women [34]. An overall thickness 
greater than 4mm to 5mm could be treated as abnormal. 
 
 
Figure 1: One dimensional model of heat flow in the uterine cavity. 
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In our model as shown in figure 1, we consider heat transfer in one dimension throughout the 
uterine tissue. The conductivities of endometrium and myometrium are 0.542 +/- 0.008 W 
m(-1) K(-1) ( mean +/- 1 SD) and 0.536 +/- 0.012 W m(-1) K(-1) (mean +/- 1 SD) repectively 
in an in vitro analysis by Olsrud J et al. [35].  It could be well observed that there is very little 
difference in thermal conductivities of   endometrium and myometrium. The endometrium, 
myometrium and serosa are homogeneous throughout the uterine cavity; hence they could be 
treated as a single cavity, collectively called as the uterine cavity. Heat from the 5% dextrose 
water transfers through the silicone balloon into the endometrium initially followed by the 
myometrium and the serosa as indicated in the figure 1.  
An overall thickness of 20mm of uterine cavity has been considered in the model. The 
temperature at the endometrial surface is not the temperature of the fluid inside the balloon 
(Tf) but varies and is less than the fluid temperature. This variation is in accordance with 
Robin’s boundary condition and the temperature at the surface of the endometrium is 
calculated by the equation 
 
−  = ℎ( − Tf) 
 
Where k is the thermal conductivity of the tissue (Wm-1K-1), h is the overall convective heat 
transfer coefficient (Wm-2K-1), T is the temperature of the uterine cavity (°C), and Tf is the 
temperature of the fluid inside the silicone balloon (°C). 
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2.2. PENNES BIO HEAT EQUATION: 
To deal with variation of temperature across the uterine cavity, the famous bio-heat equation 
is used. This equation is commonly used to describe transient temperature in tissues [36].  
The Pennes bio-heat equation is: 
  = ∇∇+  − +   
 
where ρ is the density (kg m-3), c is the specific heat capacity (J kg-1 K-1), T is the temperature 
of the tissue (°C), τ is the time (s), k is thermal conductivity (Wm-1K-1), ωb is blood perfusion 
rate (mb3 mt-3 s-1), qm is the rate of metabolic heat generation by the tissue (W m-3). The 
suffixes b and t indicate blood and tissue respectively. 
The left hand side indicates the rate of sensible heat that could be stored in a tissue which is 
equated to the right hand side involving the sum of three terms; conduction of heat by local 
temperature gradient in the tissue of our concern, the heat transport due to convection 
between the blood and the tissue, and the rate of heat that is generated as a result of 
metabolism. 
 
The boundary conditions that are considered in this equation are: 
 
At τ =0,   T=37 °C  for all x, 
x=0,   T<Tf        for all τ , 
x=∞,   T=37 °C  for all τ . 
where τ is time (s). 
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2.3. THERMAL INJURY INTEGRAL: 
While the above bio-heat equation describes the transient heat transfer in tissues, there is 
another expression that describes the degree of tissue injury computed by means of a 
cumulative damage integral which is [36]: 
 
, =   exp	 − ∆ERT(x,τ)	 
 
where (x,τ) is the degree to which the tissue is injured, A is the kinetic expression frequency 
factor (s-1), ΔE is the activation energy required for the burn reaction (J mol-1), R is the 
universal gas constant (8.314 J mol-1 K-1), and T(x,τ) is the temperature of the tissue as a 
function of position and time (°C). 
 
The parameters A and ΔE depend on the type of tissue under consideration [14]. For human 
arterial samples the values of A and ΔE were found to be 5.6 x 1063 (± 8 x 1012) s-1 and 4, 
30,000 (± 85,000) J mole-1 respectively [8, 14]. Most of the properties of uterine cavity and 
arterial samples were found to be the same; hence the values for arterial tissues could be 
considered in the study [14]. By means of these constants, when the damage integral () is 
equal to or exceeds 1, about 63% of the protein in the tissue is denatured [37]. Both the 
arterial and uterine tissues are composed of collagen fibrils and smooth muscle tissue which 
have some similar compositional characteristics. Hence a similar response to thermal injury 
could be expected and hence the parameters used in the model are valid [14]. 
 
The parameters used in our current model of heat transfer are tabulated as follows: 
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Table 1. Parameter values used in model. [2, 7, 27, 39] 
 
 
Parameter 
 
Denotion 
 
Value 
 
Units 
 
Density of tissue 
 
ρt 
 
1060 
 
kg m-3 
 
Density of blood 
 
ρb 
 
1080 
 
kg m-3 
 
Specific heat capacity of tissue 
 
ct 
 
3600 
 
J kg-1 K-1 
 
Specific heat capacity of blood 
 
cb 
 
3500 
 
J kg-1 K-1 
 
Thermal conductivity of tissue 
 
kt 
 
0.56 
 
W m-1K-1 
 
Blood perfusion rate 
 
ωb 
 
0.0028 
 
mb3 mt-3 s-1 
 
Temperature of blood supply 
 
Tb 
 
37 
 
°C 
 
Rate of metabolic heat generated  
by the tissue 
qm 170 W m-3 
 
Frequency factor of kinetic 
expression 
 
A 5.6x1063 s-1 
Activation energy for burn 
reaction 
E 4,30,000 J mol-1 
 
Universal gas constant 
 
R 
 
8.314 
 
J mol-1 K-1 
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The temperature at the surface of the endometrium would be the highest temperature of the 
cavity during the treatment time and is gradually cooled to body temperature (37°C) later on 
during the cooling period. When 63% of the protein is denatured, it results in coagulation of 
blood [41].  
 
2.4. ASSUMPTIONS: 
Certain assumptions are made to simplify the model. They are: 
· The uterine wall can be considered as a one-dimensional structure, since the heat 
transfer takes place in one dimension from the heated fluid in the balloon along the 
thickness of the uterine cavity. Moreover, the length of the tissue is far larger when 
compared to its thickness; therefore one dimensional geometry could be justified. 
· The uterine cavity is assumed to be a homogeneous cavity and hence the tissue 
properties like kt, ρt, ct remain constant, and are independent of temperature. 
· Blood perfusion rate though independent of temperature, is assumed to stop when the 
thermal injury integral equals to or is greater than 1 as a result of blood coagulation. 
· Initial temperature of the uterine cavity was assumed to be the temperature of the 
body (37°C). 
· The temperature of blood perfusion at the tissue was assumed to be that at normal 
body temperature that is at 37 °C. 
 
2.5 SOLUTION APPROACH: 
A 20mm domain is considered in this study. The heat transfer along the thickness is 
studied using Pennes bio-heat equation in Cartesian coordinate system. Fine grids are laid 
near the endometrium lining while coarse grids are used near the serosa. Central 
difference method is used to discretise the diffusion term while implicit three time level 
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scheme is used for time marching which results in second order accuracy in spatial and 
temporal dimensions. Tissue damage integral is calculated using trapezoidal rule.  
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CHAPTER-3 
RESULTS AND DISCUSSION 
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When the uterine cavity is exposed to the fluid temperature, the heat transfer takes place 
across the uterine cavity and in the process it ablates the tissue to a certain depth which is 
dependent on fluid temperature and overall convective heat transfer coefficient. The effect of 
overall heat transfer coefficient and the fluid temperature on the tissue damage is studied by 
the proposed mathematical model. In the present study, different overall convective heat 
transfer coefficient values 125 Wm-2K-1, 250 Wm-2K-1, 500 Wm-2K-1, 1000 Wm-2K-1, 2000 
Wm-2K-1, and 4000 Wm-2 K-1 are employed and the variation of tissue damage is studied for 
each of the values. A similar study is done by employing different fluid temperatures 87°C, 
90°C, and 93°C which are usually used in uterine balloon therapy. Moreover, thermal injury 
integral plays an important role in determining the depth of necrosis.  
 
3.1. VALIDATION OF MODEL: 
Mathematical model formulated in this study is validated by comparing the mathematical 
results with the published experimental results from the literature. Endometrial ablation by 
means of a thermal balloon was carried out in four patients in London in an initial study on 
thermal ablation. After the ablation, hysterectomy was carried out to study the potential for 
uterine cavity perforation, rupture, and thermal effects. The fluid temperature inside the 
balloon was 92 °C and the treatment time was 6 min [36]. For each case, the maximum 
temperature of the tissue at a thickness of 0.5mm is analysed. The thickness up to which the 
tissue has undergone necrosis was examined and the results were tabulated.  
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Table 2: Validation of mathematical model with experimental values 
 
              Case no: Maximum temperature at 
0.5mm depth 
Zone of destruction 
1 87.7 5.1 
2 89.4 3.3 
3 89.7 4.2 
4 89.4 4.3 
Average of experimental 
outcomes 
89.0±0.7 4.2±0.6 
mathematical model 
outcomes 
89.32 4.18 
 
From the Table 1, it is observed that the outcomes of the model lie within the range of 
experimental outcomes from published literature. This proves the validity of the model. 
 
3.2 EFFECT OF DIFFERENT OVERALL CONVECTIVE HEAT TRANSFER 
COEFFICIENTS ON THERMAL INJURY: 
In this section, different values of overall convective heat transfer coefficient are considered 
and its effect on the depth of ablation is analyzed. Overall convective heat transfer 
coefficients for the thermal balloon ablation system may vary and a set of possible values are 
chosen in this study. A graph is drawn for thermal injury integral versus the thickness of 
uterine cavity for different overall heat transfer coefficients at a temperature of 87°C. 
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Figure 2: Variation of ablation depth for different overall convective 
 heat transfer coefficients. 
 
From Figure 2, it is observed that the ablation depths increase with increase in the overall 
convective heat transfer coefficient. But this increase is desirable only till the ablation depth 
is considerable. However, the variation of thermal injury integral shows no significant 
increase when the overall convective heat transfer coefficient is increased from 2000 Wm-2K-
1 to 4000 Wm-2K-1. When the lower values of overall convective heat transfer coefficient are 
considered, there is a remarkable increase in the depths of ablation with increase in overall 
heat transfer coefficient. So, a fluid with an overall convective heat coefficient should be 
chosen such that the depth of ablation is sufficient enough to destroy the excessive uterine 
tissue.  
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Table 3: Ablation depths for different 
overall convective heat transfer coefficients. 
 
Overall convective heat 
transfer coefficient(h) in 
Wm-2K-1 
Ablated depth (x) in mm. 
125 0.10 
250 1.83 
500 2.92 
1000 3.41 
2000 3.77 
4000 3.77 
 
The ablation depth that has occurred with fluids of varying overall convective heat transfer 
coefficient are represented in the Table 3 which gives us an insight in choosing a better fluid 
that gives reliable ablation depths. As discussed above, the difference in the depths of 
ablation is very little at very high convective heat transfer coefficient; and the same is 
observed from the table. Moreover, abnormality of the endometrium is associated when the 
thickness of the endometrium is above 4-5mm. In this regard 4mm may be chosen as the 
minimal thickness above which abnormality may occur. From the Table 3 it is observed that 
the ablation is below 4mm even for very high values of convective heat transfer coefficient at 
a temperature of 87°C. Fluids with higher temperature ablate the tissue to greater depths and 
the choice of fluid temperature is done on the basis of patient consideration. For patients who 
require a greater depth of ablation, temperatures above 87°C should be used.  
 
3.3 EFFECT OF FLUID TEMPERATURE ON THERMAL INJURY: 
The temperatures used for endometrial ablation by thermal balloon procedure vary from 87° 
to 93°C usually. The variation in temperature caused across the uterine cavity by this range of 
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temperatures is studied in this section. From the calculated depths of ablation, the 
temperature dependent variation of ablation is obtained.  
 
Figure 3: Variation of ablation depths for different fluid temperatures. 
 
Thermal injury integral is plotted against the thickness of uterine tissue for different 
temperature values that are usually used in thermal balloon ablation as shown in Figure 3. 
Three temperature values 87°C, 90°C, and 93°C are chosen. As the temperature increases, 
irreversible damage that is induced into the tissue also increases. In this figure the overall 
convective heat transfer coefficient has been considered to be 1000 Wm-2K-1. At this value of 
overall convective heat transfer coefficient, the tissue damage is sufficient enough to destroy 
the undesired tissue. The following table indicates the thickness of ablated tissue at different 
temperatures. 
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Table4: Ablation depths for different fluid temperatures 
Temperature of fluid (Tf) in 
°C 
Ablation depth  (x) in mm. 
87 3.41 
90 3.77 
93 4.39 
 
As indicated in Table 4 the variation of the ablation depth is considerable. Since, a minimal 
thickness of about 4mm is present in the endometrial lining; the depth up to which necrosis is 
needed could be determined by this study. A temperature of 93°C has a very high ablation 
depth in consideration to the other two values which is 4.39mm and is preferred for a thicker 
endometrium. The other two values have an ablation depth less than 4mm indicating that they 
are safer to be used when the minimal endometrium thickness for abnormality is considered 
to be 4mm. 
 
 
 
3.4. EFFECT OF OVERALL CONVECTIVE HEAT TRANSFER COEFFICIENT      
       ON THE ENDOMETRIAL SURFACE TEMPERATURE: 
As the overall convective heat transfer coefficient varies, the rise in temperature at different 
distances from the surface of the endometrium also varies. This study is helpful in deciding 
the convective heat transfer coefficient of the fluid to be used in the balloon. If the convective 
heat transfer coefficient is too high, the rise in temperature due to convection also increases 
which may result in damage of the tissues nearer to the uterus. However, such an adverse 
effect is rare and can be attributed as a procedural risk. But, to know the transfer of heat by 
convection and the temperature rise caused as a result of this, it is necessary to study the 
dependence of overall heat transfer coefficient on the rise in temperature. The graph below 
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indicates the temperature across uterine cavity for different values of convective heat transfer 
coefficient. 
 
Figure4: Variation of temperatures at endometrial surface for different  
overall convective heat transfer coefficients 
 
 
As observed from Figure 4, there is a sharp rise in temperature as overall heat transfer 
coefficient increases from lower values to higher values. However, this increase is very slight 
when the overall heat transfer coefficient reaches higher values. It is clearly observed from 
the graph that the difference in rise of temperature caused by overall convective heat transfer 
coefficients at 2000 Wm-2K-1 and 4000 Wm-2K-1 is very little when compared to the 
difference in rise of temperatures when the overall convective heat transfer coefficients 
varied from 125 Wm-2K-1 to 250 Wm-2K-1. This indicates that the difference in the rise of 
temperature decreases with increasing values of overall convective heat transfer coefficient. 
The above results are obtained when fluid temperature is 87°C 
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Table 5: Effect of various overall convective heat transfer coefficients 
 on temperatures at endometrium surface 
Overall convective heat 
transfer coefficient (h) 
inW m-2K-1 
Temperature at the 
surface of endometrium 
(Ts) in °C 
125 67.37 
250 76.50 
500 81.66 
1000 84.31 
2000 85.64 
4000 86.31 
 
From the Table 5, it is observed that as the overall convective heat transfer coefficient 
increases, the temperature at the surface of the endometrium also increases which is obvious. 
But the difference in rise of temperatures with varying overall convective heat transfer 
coefficient at endometrial surface is high for lower values and this difference in rise gradually 
decreases as the convective heat transfer coefficients reaches higher values. 
 
3.5. EFFECT OF FLUID TEMPERATURE ON ENDOMETRIAL SURFACE     
       TEMPERATURES: 
 
When fluids at different temperatures are employed in the silicone balloon, the rise in 
temperature across the uterine cavity varies. This variation is studied by plotting a graph of 
temperature against the thickness of the tissue for various temperatures of the fluid. Three 
temperatures 87°C, 90°C , and 93°C which are generally used have been taken into 
consideration and the variation of temperatures at the endometrium surface and at various 
depths in the tissue are examined from the graph.  
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Figure 5: Variation of temperatures at endometrial surface for  
different fluid temperatures. 
 
 
Figure 5 indicates the variation caused in temperature at the endometrial surface when 
different fluid temperatures are used. The temperature at the surface of the endometrium in 
contact with the balloon is not the same as the fluid temperature due to convective heat loss. 
In all the cases overall convective heat transfer coefficient is taken to be 1000Wm-2K-1. It can 
be seen that as the fluid temperature increases, the temperature of the tissue also increases. 
 Below is a table that represents temperatures at endometrial surface for different fluid 
temperatures used in the balloon. 
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Table 6: Effect of various fluid temperatures on temperatures 
at endometrium surface 
Temperature of the 
fluid (Tf) in °C 
Temperature at the 
surface of 
endometrium (Ts) in 
°C 
87 84.31 
90 87.23 
93 90.15 
 
From Table 6, it can be observed that the temperature at the surface of endometrium is less 
than the actual fluid temperature which could be accounted to convective heat loss. The 
values tabulated above are considered for a fluid with an overall convective heat transfer 
coefficient 1000 Wm-2 K-1. 
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CONCLUSION: 
A thermal balloon endometrial ablation model is presented. The mathematical findings lie 
within the range of experimental values which proves the validity of the presented model. 
The effect due to variation of overall convective heat transfer coefficient on ablation depth is 
studied. Along with it, the effect of different fluid temperatures and its influence on the 
ablation depth is discussed. Similar study has been performed for studying influence of 
varying convective heat transfer coefficients on the temperature across the uterine cavity. 
However, there might be some procedural risks and some adverse effects associated with 
thermal balloon ablation. Hence, a clear pathological history and good examination is 
required before performing thermal balloon ablation. There might be some pathological 
responses that may cause inaccuracy of the results from those studied in the current model. 
Therefore, proper care should be taken while implementing the current model.  
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